Home
About
Overview
Sharing Data
ORCID
Help
History (4)
American Medical Association
Gene-based therapy for alpha-1 antitrypsin deficiency.
RNA processing bodies, peroxisomes, Golgi bodies, mitochondria, and endoplasmic reticulum tubule junctions frequently pause at cortical microtubules.
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gene-based therapy for alpha-1 antitrypsin deficiency.
Mueller C, Flotte TR. Gene-based therapy for alpha-1 antitrypsin deficiency. COPD. 2013 Mar; 10 Suppl 1:44-9.
View in:
PubMed
subject areas
Adenoviridae
alpha 1-Antitrypsin
alpha 1-Antitrypsin Deficiency
Dependovirus
DNA, Recombinant
Genetic Therapy
Genetic Vectors
Humans
Liposomes
RNA, Small Interfering
authors with profiles
Terence R Flotte MD